ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy

Clinical trial NCT07410611 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07410611
Sponsor: Hebei Medical University Fourth Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Patients With Advanced Oligometastatic Non-small Cell Lung Cancer (NSCLC) Who Have Tested Positive for EGFR Mutations Confirmed by Histopathological Examination

Start date: 2026-02-10
Primary completion: 2030-02-28
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.